» Articles » PMID: 15548585

GDF11 Modulates NGN3+ Islet Progenitor Cell Number and Promotes Beta-cell Differentiation in Pancreas Development

Overview
Journal Development
Specialty Biology
Date 2004 Nov 19
PMID 15548585
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

Identification of endogenous signals that regulate expansion and maturation of organ-specific progenitor cells is a major goal in studies of organ development. Here we provide evidence that growth differentiation factor 11 (GDF11), a member of the TGF-beta ligand family, governs the number and maturation of islet progenitor cells in mouse pancreas development. Gdf11 is expressed in embryonic pancreatic epithelium during formation of islet progenitor cells that express neurogenin 3. Mice deficient for Gdf11 harbor increased numbers of NGN3+ cells, revealing that GDF11 negatively regulates production of islet progenitor cells. Despite a marked expansion of these NGN3+ islet progenitors, mice lacking Gdf11 have reduced beta-cell numbers and evidence of arrested beta-cell development, indicating that GDF11 is also required for beta-cell maturation. Similar precursor and islet cell phenotypes are observed in mice deficient for SMAD2, an intracellular signaling factor activated by TGF-beta signals. Our data suggest that Gdf11 and Smad2 regulate islet cell differentiation in parallel to the Notch pathway, which previously has been shown to control development of NGN3+ cells. Thus, our studies reveal mechanisms by which GDF11 regulates the production and maturation of islet progenitor cells in pancreas development.

Citing Articles

Novel insights into the pleiotropic health effects of growth differentiation factor 11 gained from genome-wide association studies in population biobanks.

Strosahl J, Ye K, Pazdro R BMC Genomics. 2024; 25(1):837.

PMID: 39237910 PMC: 11378601. DOI: 10.1186/s12864-024-10710-7.


Expression profiling by high-throughput sequencing reveals GADD45, SMAD7, EGR-1 and HOXA3 activation in Myostatin (MSTN) and GDF11 treated myoblasts.

Braun P, Alawi M, Saygi C, Pantel K, Wagers A Genet Mol Biol. 2024; 47(2):e20230304.

PMID: 39012095 PMC: 11256782. DOI: 10.1590/1678-4685-GMB-2023-0304.


GDF11: An emerging therapeutic target for liver diseases and fibrosis.

Habibi P, Falamarzi K, Dehdari Ebrahimi N, Zarei M, Malekpour M, Azarpira N J Cell Mol Med. 2024; 28(7):e18140.

PMID: 38494851 PMC: 10945076. DOI: 10.1111/jcmm.18140.


GDF11 and aging biology - controversies resolved and pending.

Ben Driss L, Lian J, Walker R, Howard J, Thompson T, Rubin L J Cardiovasc Aging. 2024; 3(4).

PMID: 38235060 PMC: 10793994. DOI: 10.20517/jca.2023.23.


A Supportive Role of Mesenchymal Stem Cells on Insulin-Producing Langerhans Islets with a Specific Emphasis on The Secretome.

Sionov R, Ahdut-HaCohen R Biomedicines. 2023; 11(9).

PMID: 37761001 PMC: 10527322. DOI: 10.3390/biomedicines11092558.